# F. Hoffmann-La Roche

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/f-hoffmann-la-roche/

## Facts

| Field | Value |
| --- | --- |
| Country | CH |
| Description | Swiss healthcare company |
| OpenAlex ID | https://openalex.org/F4320309432 |
| ROR ID | https://ror.org/00by1q217 |
| Works | 10,544 |

## Funder papers

- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers](https://scholariq.org/papers/molecular-biomarkers-of-disease-outcomes-and-mechanisms-of-acquired-resistance/)
- [Development and Psychometric Validation of the 27 Item Zarit CaregiverInterview for Alzheimer’s Disease (ZCI-AD-27)](https://scholariq.org/papers/development-and-psychometric-validation-of-the-27-item-zarit-caregiverinterview/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.